Found 2 results
Filters: Author is A.L.C. Trindade  [Clear All Filters]
E. R. Valadares, Trindade, A. L. C., Oliveira, L. R., Godard, A. L. B., Arantes, R. R., Daker, M. V., Viana, B. M., Haase, V. G., Jardim, L. B., and Lopes, G. C., Novel exon nucleotide deletion causes adrenoleukodystrophy in a Brazilian family, vol. 10, pp. 65-74, 2011.
Berger J, Molzer B, Fae I and Bernheimer H (1994). X-linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes. Biochem. Biophys. Res. Commun. 205: 1638-1643. PMid:7811247   Bezman L, Moser AB, Raymond GV, Rinaldo P, et al. (2001). Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann. Neurol. 49: 512-517. PMid:11310629   Blaw ME (1970). Melanodermic Type Leucodystrophy (Adrenoleukodystropy). In: Leucodystrophies and Poliodystrophies (Vinken PJ and Bruyn GWE, eds.). North Holland Publishing, Amsterdam, 128-133.   Boehm CD, Cutting GR, Lachtermacher MB, Moser HW, et al. (1999). Accurate DNA-based diagnostic and carrier testing for X-linked adrenoleukodystrophy. Mol. Genet. Metab. 66: 128-136. PMid:10068516   Dean M and Santis G (1994). Heterogeneity in the severity of cystic fibrosis and the role of CFTR gene mutations. Hum. Genet. 93: 364-368. PMid:7513291   Eichler EE, Budarf ML, Rocchi M, Deaven LL, et al. (1997). Interchromosomal duplications of the adrenoleukodystrophy locus: a phenomenon of pericentromeric plasticity. Hum. Mol. Genet. 6: 991-1002. PMid:9215666   El-Deiry SS, Naidu S, Blevins LS and Ladenson PW (1997). Assessment of adrenal function in women heterozygous for adrenoleukodystrophy. J. Clin. Endocrinol. Metab. 82: 856-860. PMid:9062496   Fanen P, Guidoux S, Sarde CO, Mandel JL, et al. (1994). Identification of mutations in the putative ATP-binding domain of the adrenoleukodystrophy gene. J. Clin. Invest. 94: 516-520. PMid:8040304 PMCid:296124   Grosko AP and Ferreira RJ (2006). Aspectos biológicos e moleculares da adrenoleucodistrofia. Arq. Ciênc. Saúde Unipar 10: 43-47.   Higgins CF (1992). ABC transporters: from microorganisms to man. Annu. Ver. Cell Biol. 8: 67-113. PMid:1282354   Igarashi M, Schaumburg HH, Powers J, Kishmoto Y, et al. (1976). Fatty acid abnormality in adrenoleukodystrophy. J. Neurochem. 26: 851-860. PMid:965973   Jardim LB, da Silva AC, Blank D, Villanueva MM, et al. (2010). X-linked adrenoleukodystrophy: clinical course and minimal incidence in South Brazil. Brain Dev. 32: 180-190. PMid:19269120   Kemp S and Wanders RJ (2007). X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment. Mol. Genet. Metab. 90: 268-276. PMid:17092750   Kok F, Neumann S, Sarde CO, Zheng S, et al. (1995). Mutational analysis of patients with X-linked adrenoleukodystrophy. Hum. Mutat. 6: 104-115. PMid:7581394   Korenke GC, Fuchs S, Krasemann E, Doerr HG, et al. (1996). Cerebral adrenoleukodystrophy (ALD) in only one of monozygotic twins with an identical ALD genotype. Ann. Neurol. 40: 254-257. PMid:8773611   Lachtermacher MB, Seuanez HN, Moser AB, Moser HW, et al. (2000). Determination of 30 X-linked adrenoleukodystrophy mutations, including 15 not previously described. Hum. Mutat. 15: 348-353.<348::AID-HUMU7>3.0.CO;2-N   Loes DJ, Fatemi A, Melhem ER, Gupte N, et al. (2003). Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology 61: 369-374. PMid:12913200   Mahmood A, Dubey P, Moser HW and Moser A (2005). X-linked adrenoleukodystrophy: therapeutic approaches to distinct phenotypes. Pediatr. Transplant. 9 (Suppl 7): 55-62. PMid:16305618   Miller SA, Dykes DD and Polesky HF (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215. PMid:3344216 PMCid:334765   Montagna G, Di Biase A, Cappa M, Melone MA, et al. (2005). Identification of seven novel mutations in ABCD1 by a DHPLC-based assay in Italian patients with X-linked adrenoleukodystrophy. Hum. Mutat. 25: 222. PMid:15643618   Moser AB, Kreiter N, Bezman L, Lu S, et al. (1999). Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls. Ann. Neurol. 45: 100-110.<100::AID-ART16>3.0.CO;2-U   Moser HW (2006). Therapy of X-linked adrenoleukodystrophy. NeuroRx 3: 246-253. PMid:16554262   Moser HW and Moser AB (1996). Peroxisomal disorders: overview. Ann. N. Y. Acad. Sci. 804: 427-441. PMid:8993562   Moser HW, Moser AB, Frayer KK, Chen W, et al. (1981). Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids. Neurology 31: 1241-1249. PMid:7202134   Moser HW, Powers JM and Smith KD (1995). Adrenoleukodystrophy: molecular genetics, pathology, and Lorenzo's oil. Brain Pathol. 5: 259-266. PMid:8520725   Moser HW, Smith KD, Watkins PA, Powers J, et al. (2001). X-linked Adrenoleukodystrophy. In: The Metabolic and Molecular Bases of Inherited Disease (Scriver CR, Beaudet AL, Sly WS and Valle D, eds.). McGraw Hill, New York, 3257-3301.   Moser HW, Mahmood A and Raymond GV (2007). X-linked adrenoleukodystrophy. Nat. Clin. Pract. Neurol. 3: 140-151. PMid:17342190   Mosser J, Douar AM, Sarde CO, Kioschis P, et al. (1993). Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361: 726-730. PMid:8441467   Pan H, Xiong H, Wu Y, Zhang YH, et al. (2005). ABCD1 gene mutations in Chinese patients with X-linked adrenoleukodystrophy. Pediatr. Neurol. 33: 114-120. PMid:16087056   Peters C, Charnas LR, Tan Y, Ziegler RS, et al. (2004). Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 104: 881-888. PMid:15073029   Siemerling E and Creutzfeldt HG (1923). Bronzekrankheit und sklerosierende Encephalomyelitis. Arch. Psychiatr. Nervkrankh. 68: 217-244.   Smith KD, Sack G, Beaty T, Bergin A, et al. (1991). A genetic basis for the multiple phenotypes of X-linked adrenoleukodystrophy. Am. J. Hum. Genet. 49 (Suppl): 165.   van der Knaap MS and Valk J (2005). X-linked Adrenoleukodystrophy. In: Magnetic Resonance of Myelination and Myelin Disorders (van der Knaap MS and Valk J, eds.). 3rd edn. Springer, New York, 176-190.   van Geel BM, Assies J, Weverling GJ and Barth PG (1994). Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in The Netherlands: a survey of 30 kindreds. Neurology 44: 2343-2346. PMid:7991123   van Geel BM, Koelman JH, Barth PG and Ongerboer de Visser BW (1996). Peripheral nerve abnormalities in adrenomyeloneuropathy: a clinical and electrodiagnostic study. Neurology 46: 112-118. PMid:8559356   van Geel BM, Bezman L, Loes DJ, Moser HW, et al. (2001). Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann. Neurol. 49: 186-194.<186::AID-ANA38>3.0.CO;2-R   van Roermund CW, Visser WF, Ijlst L, van Cruchten A, et al. (2008). The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters. FASEB J. 22: 4201-4208. PMid:18757502